The battle for dominance in the global exchange market between the U.S. and Canadian dollars is mirrored in the magic mushroom industry. The rise of online mushroom dispensaries in Vancouver and other cities is a testament to this. However, the question remains: can this growth keep up with the rapid expansion of America’s psychedelic industry? Let’s delve into this.
[toc]
Summarized Takeaways:
- Oregon was the first state to legalize the therapeutic use of magic mushrooms, administered by licensed professionals.
- In 2020, Canada’s Health Minister permitted four terminally ill cancer patients to use magic mushrooms for palliative care.
- The University of British Columbia is conducting a 24-week Phase 2 trial called Clairvoyant, which explores psilocybin-assisted therapy for adults suffering from alcohol abuse disorder.
The Rapid Growth of the Magic Mushroom Industry in the United States.
The magic mushroom industry in the U.S. has grown rapidly, challenging cannabis as the leading narcotic. This growth signifies an increased societal acknowledgment of the potential therapeutic applications of the substance.
Emphasis on Mental Health
Medical professionals are keen to explore its potential in treating a variety of mental health conditions, including depression, anxiety, and PTSD. The promising results from various studies have sparked interest among private pharmaceutical companies to further research its medicinal benefits.
This growing interest extends beyond healthcare and has a significant positive impact on the economy. Startups and research initiatives are focusing their efforts on the development of psilocybin.
There is a surge in clinical evidence supporting the use of magic mushrooms in treating certain illnesses. NIDA Director Nora Volkow has underscored the burgeoning proof of psychedelics having “considerable potential” for medical treatments.
Legal Milestones
- Oregon Measure 109: Oregon made a landmark decision in 2020 by becoming the first state to legalize the therapeutic use of psilocybin, administered by administer controlled doses. This groundbreaking judgement has paved the way for other states to adopt a similar approach.
